U.S. Online Retail and Ecommerce Stock News

NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Summit Therapeutics Enters FDA Review As Ivonescimab Trials Broaden Potential

Summit Therapeutics (NasdaqGM:SMMT) had its Biologics License Application for ivonescimab, in combination with chemotherapy, accepted by the US FDA for EGFR mutated advanced non squamous non small cell lung cancer after TKI therapy. The company is running several late stage clinical trials, and recent international Phase III results support expanding ivonescimab development beyond lung cancer. Ivonescimab is also being studied in colorectal cancer, reflecting broader pipeline ambitions...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Assessing Radware (RDWR) Valuation After New Agentic AI Protection Security Launch

Why Radware’s new AI security launch matters for shareholders Radware (RDWR) has pushed further into AI security with its Agentic AI Protection Solution, a product aimed at tackling risks tied to AI agents, prompt attacks, tool abuse, and sensitive data exposure. The launch builds on Radware’s work around threats like the recently identified ZombieAgent vulnerability and follows the earlier LLM Firewall release. Together, these developments give investors fresh context for thinking about how...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Q2 Loss Narrows To US$42.6m And Tests Profitability Narratives

Atlassian (TEAM) has just posted Q2 2026 results with revenue of US$1.6b and a basic EPS loss of US$0.16, alongside trailing twelve month revenue of US$5.8b and a basic EPS loss of US$0.72 that keeps the company in the red on a full year view. The company has seen quarterly revenue move from US$1.3b in Q2 2025 to US$1.6b in Q2 2026, while quarterly basic EPS over the same periods shifted from a loss of US$0.15 to a loss of US$0.16. This sets up this release as another checkpoint on how...
NYSE:DBD
NYSE:DBDTech

Does Diebold Nixdorf (DBD) Share Price Reflect Its Cash Flow Strength?

If you are wondering whether Diebold Nixdorf at US$71.81 is priced attractively or asking too much for its prospects, this overview offers a clear look at what the current share price might imply. The stock has posted returns of 4.1% over the past week, 6.5% over the last 30 days and 12.3% year to date, with a 61.2% return over the past year that may have changed how some investors view its risk and reward profile. Recent company news has focused on Diebold Nixdorf's role in providing...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

VeriSign’s Uptime Record Meets Security Push And Share Price Pullback

VeriSign reports 28 consecutive years of 100% domain resolution uptime. The company records its highest level of new domain registrations to date. VeriSign introduces new services focused on online security and stability. VeriSign, trading under NasdaqGS:VRSN, is drawing attention as it pairs a long running record of 100% domain resolution uptime with record high new domain registrations. The stock last closed at $224.17, with a 1 year return of 2.1% and a 5 year return of 11.7%. This...
NasdaqGM:AMAL
NasdaqGM:AMALBanks

Is Amalgamated Financial’s (AMAL) Embrace Loan Partnership a Clue to Its Mortgage Ambitions?

Embrace Home Loans recently announced an agreement with Amalgamated Bank under which Embrace will originate and service residential mortgages for the bank’s customers on a tailored platform. The arrangement allows Amalgamated Bank to broaden its mortgage offering without building its own full-scale origination infrastructure, while still keeping customer relationships at the center of the process. Next, we’ll examine how outsourcing mortgage origination to Embrace Home Loans could influence...
NYSE:RNR
NYSE:RNRInsurance

A Look At RenaissanceRe (RNR) Valuation After Strong Earnings And Share Buybacks

Why RenaissanceRe’s latest earnings are drawing investor attention RenaissanceRe Holdings (RNR) has come into focus after reporting fourth quarter and full year 2025 results, alongside sizable share repurchases, that sharply contrast with the prior year, particularly on net income and earnings per share. See our latest analysis for RenaissanceRe Holdings. RenaissanceRe’s latest earnings and extensive buybacks appear to sit behind a 10.03% 1 month share price return and a 10.40% year to date...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Is Azenta (AZTA) Now Pricing In Too Much Pessimism After Steep Share Price Slide?

If you are wondering whether Azenta's current share price reflects its true worth, you are not alone. This article is built to help you connect the recent share moves with what the underlying valuation is saying. The stock closed at US$28.72, with returns of a 26.1% decline over 7 days, 24.3% decline over 30 days, 14.0% decline year to date, 45.1% decline over 1 year, 35.9% decline over 3 years and 68.3% decline over 5 years. These figures may change how investors think about both risk and...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

SkyWest Deepens United And Delta Ties With New E175 Fleet Shift

SkyWest (NasdaqGS:SKYW) announced multi year contract extensions with United Airlines and Delta Air Lines. The company also reported the delivery of new E175 aircraft tied to these agreements. For you as an investor, the key point is that SkyWest, a major regional airline operator, is deepening its ties with two of the largest U.S. carriers through these renewed contracts. The addition of new E175 aircraft fits within the broader regional aviation focus on fuel efficient, right sized jets...
NYSE:CNS
NYSE:CNSCapital Markets

Is Cohen & Steers (CNS) Pricing Look Stretched After Recent Share Price Declines

If you are wondering whether Cohen & Steers is priced attractively today, you are not alone. This article will walk through what the current share price may be implying about value. The stock recently closed at US$62.71, with returns of a 2.4% decline over 7 days, 7.8% decline over 30 days, 1.4% decline year to date, 27.2% decline over 1 year and 6.3% decline over 3 years, while the 5-year return stands at 7.3%. Recent market attention has focused on how asset managers are being priced amid...
NYSE:CSL
NYSE:CSLBuilding

A Look At Carlisle Companies (CSL) Valuation After New Results And 2026 Guidance

Carlisle Companies (CSL) has drawn fresh investor attention after releasing fourth quarter and full year 2025 results, issuing 2026 revenue guidance, and updating its capital returns through share repurchases and a newly affirmed dividend. See our latest analysis for Carlisle Companies. The latest earnings release, 2026 revenue guidance and update on buybacks and dividends arrived alongside strong share price momentum. The 7 day share price return of 18.47% and the 90 day share price return...